Retrophin Inc (NASDAQ:RTRX)

26.64
Delayed Data
As of Apr 19
 +0.20 / +0.76%
Today’s Change
15.55
Today|||52-Week Range
28.25
+26.44%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close26.44
Today’s open26.45
Day’s range26.38 - 27.07
Volume178,203
Average volume (3 months)301,096
Market cap$1.0B
Data as of 4:00pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)-19.38%
Earnings growth (this year)+3.25%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+15.98%
P/E ratioNM
Price/Sales5.27
Price/Book3.47

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...-0.84-4.98%
EDITEditas Medicine Inc-0.54-1.53%
EPZMEpizyme Inc-0.50-3.02%
----
Data as of 4:00pm ET, 04/19/2018

Financials

Next reporting dateMay 2, 2018
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$154.9M
Annual profit (last year)-$59.7M
Net profit margin-38.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil F. McFarlane
Corporate headquarters
San Diego, California

Forecasts